Rachel E. Gate
Impact in
- Oncology top 5%
- CAR-T cell therapy research
Papers in
-
- Single-cell and spatial transcriptomics 3
- CRISPR and Genetic Engineering 2
- Ion channel regulation and function 1
- Oncology 2
- CAR-T cell therapy research 2
- Co-authors
- Alexander Marson (6 shared papers)Chun Ye (6 shared papers)Kathrin Schumann (2 shared papers)Wendell A. Lim (1 shared paper)Kole T. Roybal (1 shared paper)Levi J. Rupp (1 shared paper)Meena Subramaniam (3 shared papers)Dimitre R. Simeonov (1 shared paper)
- Journals
- Nature Biotechnology (2 papers)Proceedings of the National Academy of Sciences (1 paper)Cell (1 paper)Nature Immunology (1 paper)Neuron (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Rachel E. Gate
8 papers receiving 2.0k citations
Rachel E. Gate's Hit Papers
Peers
Comparison fields: 5 of 99
- Business and International Management 80
- Oncology 704
- Immunology 529
- Molecular Biology 1.2k
- Aging 26
Countries citing papers authored by Rachel E. Gate
This map shows the geographic impact of Rachel E. Gate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Gate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Gate more than expected).
Fields of papers citing papers by Rachel E. Gate
This network shows the impact of papers produced by Rachel E. Gate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Gate. The network helps show where Rachel E. Gate may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel E. Gate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells Hit paper breakdown → | 2017 | 608 |
| 2 | Generation of knock-in primary human T cells using Cas9 ribonucleoproteins Hit paper breakdown → | 2015 | 569 |
| 3 | Multiplexed droplet single-cell RNA-sequencing using natural genetic variation Hit paper breakdown → | 2017 | 547 |
| 4 | 2016 | 200 | |
| 5 | 2018 | 56 | |
| 6 | 2012 | 24 | |
| 7 | 2024 | 10 | |
| 8 | 2020 | 4 |
About Rachel E. Gate
Rachel E. Gate is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Cardiology and Cardiovascular Medicine and Biomaterials, having authored 8 papers that have together received 2.0k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (3 papers), CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers), Cardiac electrophysiology and arrhythmias (1 paper), Nanowire Synthesis and Applications (1 paper), Ion channel regulation and function (1 paper), Advanced Nanomaterials in Catalysis (1 paper) and Neuroscience and Neuropharmacology Research (1 paper). The work is most often cited by research in Business and International Management (80 citations), Oncology (704 citations), Immunology (529 citations), Molecular Biology (1.2k citations) and Aging (26 citations). Rachel E. Gate has collaborated with scholars based in United States and Canada. Frequent co-authors include Alexander Marson, Chun Ye, Kathrin Schumann, Wendell A. Lim, Kole T. Roybal, Levi J. Rupp, Meena Subramaniam, Dimitre R. Simeonov, Jeffrey A. Bluestone and Steven Lin. Their work appears in journals such as Nature Biotechnology, Proceedings of the National Academy of Sciences, Cell, Nature Immunology and Neuron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.